TNNI3 and atrial fibrillation: Compared with patients without hs-cTnI dynamic changes, the hs-cTnI dynamic changes group tended to have a greater proportion of elderly and female patients, more comorbid AF and CAD, more previous antithrombotic therapy, higher NIHSS score on admission, less dual antiplatelet therapy, lower platelet levels, higher INR, lower eGFR, and higher mortality (all p<0.05, table 1).